论文部分内容阅读
河北省人民政府:你省《关于请批准中国制药企业投资有限公司在石家庄收购资产的函》收悉。经研究,现批复如下:一、同意中国制药企业投资有限公司(以下简称“中国制药”)向河北制药厂收购河北丰华制药有限公司69%的权益,该项收购完成后,中国制药持有河北丰华制药有限公司69%的权益。二、在上述收购活动过程中,中国制药应严格遵守境内外的有关法律、法规和规则,
Hebei Provincial People’s Government: Your province, “on the approval of China Pharmaceutical Enterprises Investment Co., Ltd. in Shijiazhuang acquisition of assets letter” received. The research is approved as follows: I. It is agreed that China Pharmaceutical Enterprise Investment Co., Ltd. (hereinafter referred to as “China National Pharmaceutical”) acquired a 69% interest in Hebei Fenghua Pharmaceutical Co., Ltd. from Hebei Pharmaceutical Factory. Upon the completion of the acquisition, Holds 69% interest in Hebei Fenghua Pharmaceutical Co., Ltd. Second, in the above acquisition activities, China Pharmaceutical strictly abide by the relevant laws and regulations at home and abroad,